“…Hangeshashinto was provided by Tsumura (Tokyo, Japan). P. gingivalis LPS (InvivoGen, California, USA, referred to as “PAMP” in this study) (see Imamura et al [ 10 ]). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and dexamethasone (Sigma-Aldrich, Missouri, USA); resatorvid and C29 (Selleck Biotech, Kanagawa, Japan); anti-IL-6 antibody and biotinylated anti-IL-6 antibody (Thermo Fisher Scientific (eBioscience), Massachusetts, USA); anti-IL-8 antibody and biotinylated anti-IL-8 antibody (R&D Systems, Minnesota, USA).…”